Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

Advancing preclinical research with reconstructed in vitro skin models mimicking non-healing wounds

Daré RG., Lopes LB., Petri-Fink A., Rothen-Rutishauser B.

Narrative Review on Chronic Wound, published in Int J Pharm X (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Int J Pharm X (2026)
Reported sample size
—
Source database
Europe PMC
PMID
41909167
PMCID
PMC13022694
DOI
10.1016/j.ijpx.2026.100518
Citations
2

Abstract (original English)

Chronic skin wounds remain a significant therapeutic challenge worldwide, primarily due to persistent inflammation, impaired function of fibroblasts and keratinocytes, defective angiogenesis, and the presence of complex polymicrobial biofilms. Conventional animal models only partially capture these human-specific pathophysiological mechanisms, limiting their predictive value for pharmacological development. Recent advances in human 3D in vitro skin models, including reconstructed human epidermis, full-thickness skin equivalents, vascularized and innervated constructs, and chronic wound-derived cell systems, provide opportunities to evaluate therapeutic strategies under controlled, human-relevant conditions. Here, we critically synthesize how engineered skin platforms recreate key pathological hallmarks of non-healing wounds, including IL-1/TNF-α-driven inflammation, RAGE-NOX4-mediated oxidative stress, MMP/TIMP imbalance, fibroblast and keratinocyte senescence, impaired HIF-1α/VEGF-dependent angiogenesis, immune polarization defects, and biofilm-associated antimicrobial tolerance. We examine scaffold-based, decellularized, and bioprinted approaches that enable the incorporation of adipocytes, endothelial cells, sensory neurons, and immune compartments, enhancing the mechanistic resolution with which chronic wound biology can be interrogated. By integrating cellular, biochemical

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research